Subject Index Volumes 77-85 Q quality-adjusted life years (QALY), costs per 79:679–680, 79:681–684 quality assessment, external see external quality assessment quality control health information systems and poverty indicators, in Tanzania 83:569–577 immunization coverage assessment 79:501–505 immunization monitoring systems 83:503–510 vaccines 78:153, 78:155–162 quality of health care child health services in developing countries 81:886–895 for children under-five, in Bangladesh 83:260–267 client satisfaction and 79:512–517 framework for dealing with 81:313 improvement, to achieve Millennium Development Goals 84:259 maternal mortality in Indonesia and 80:228–234 patient evaluations vs WHO measures 82:106–114 private and public providers of antenatal care, in Tanzania 81:116–122 private sector, in low-income countries 80:325–330 for rape survivors in South Africa 83:495–502 quality of life (QoL) chronic diseases and caregivers in China 82:493–502 determinants in South Africa 82:206–212 in leprosy 77:515–517 oral health and 83:644 oral health-related (OHRQoL) measure, in oral health service planning 84:36–42 prevalence in general population 79:1047–1055 quinine and tetracycline, in malaria 77:235–243 R rabies burden of disease in Africa and Asia 83:360–368 canine, pilot vaccination campaign in Chad 81:739–744 elimination of human, in canine endemic area of Thailand 81:375–381 estimating mortality in Tanzania 80:304–310 vaccines for postexposure vaccination 78:693–698 radiation exposure, Balkans and Gulf war zones 79:274 radiographs, chest see chest radiographs radon, residential exposure to, and lung cancer 81:732–738 randomized controlled trials (RCTs) anterior chamber intraocular lenses 78:372–378 cervical cancer screening, determinants of participation, in India 85:264–272 international collaboration, in Africa 83:511–517 interventions to prevent HIV 79:1121–1132 registration 82:321, 82:397, 82:714 short-course eflornithine 78:1284–1295 see also clinical trials/research rape quality of health services in South Africa 83:495–502 see also sexual violence rare diseases essential drugs for 84:686, 84:745–751 see also neglected diseases; orphan drugs rationing, antiretroviral treatment, ethical and equity implications 83:541–547 Reaching the poor with health, nutrition, and population services (Gwatkin et al) 84:920 realization of potential life years (RePLY) 85:681–687 La Recherche bibliographique en médecine et santé publique: guide d'accès (Mouillet) 85:418–419 records electronic health 83:323 medical, monitoring HAART in Botswana 84:127–131 RED, AIDS funding-raising scheme 84:263–264 Red Cross, role in Uganda's Ebola outbreak 79:267 Redesigning humans – our inevitable genetic future (Stock) 80:985–986 Reducing the stigma of mental illness (Sartorius & Schulze) 84:333–334 referral compliance with IMCI recommendations in Sudan 81:708–716 difficult/impossible, severely ill children in sub-Saharan Africa 81:522–531 reflectors, to reduce road deaths in Tanzania 80:989–990 Réforme des régimes de soins de santé, La (Rilliet Howald) 84:78 refractive errors blindness caused by 79:237–243 global data for 2002 82:844–851 refrigeration, hepatitis B vaccine in Indonesian cold chain 82:99–105 refugees and displaced persons access to health care of Iraqi 85:656–657 in Afghanistan, hazards of winter 79:1000–1001 coeliac disease in children 79:541–545 mass cholera vaccination 77:837–842, 77:949–950 provision of clean drinking water 79:280–287 tuberculosis treatment and control 80:451–456 see also complex emergencies; humanitarian emergencies; wars and conflicts Regional East-African Health (REACH) Policy Initiative 84:608–612 registration, death see death certification/registration registries clinical trials see Clinical Trials Registry maternal mortality 79:561–568 thalassaemia surveillance 79:1006–1013 rehabilitation, landmine victims 81:665–670 Reichman and Hershfield's tuberculosis: a comprehensive, international approach (Raviglione) 85:418 religion, in tobacco control interventions 82:894, 82:923–927 remote sensing, for helminth control in Chad 80:783–789 RePLY (realization of potential life years) 85:681–687 reproductive behaviour, effect of son preference 78:379–388, 78:1373 reproductive health components 78:569 definition and measurement 80:407–409 evidence-based care 84:504 in Cameroon 83:895–903 and health sector reform in developing countries 80:667–674 humanitarian assistance and 77:1020 landmark global strategy 82:478 male and female, in Gambia 78:570–579 measuring 78:640–654, 78:655–666 perceived illness, women in India 79:1065–1069 socioeconomic factors 78:677–686 Reproductive health and human rights: integrating medicine, ethics and law (Cook et al) 82:549 reproductive health care services community-based, in Ghana 84:949–955 integration into primary health care 77:771–777 unmarried young people, attitudes in China 82:274–280 reproductive tract infections in Bangladesh 80:180–188 in pregnancy in Botswana 85:297–304 in rural community in Lebanon 81:639–645 rural women in Peru 82:483–492 see also sexually transmitted infections; vaginal discharge Republic of Korea doctors' strike 78:1478 morbidity and medical care utilization after recent economic crisis 81:567–572 Plasmodium vivax malaria 84:827–834 research and development (R&D) anti-tuberculosis drugs 80:428, 80:429, 80:517–519 antimicrobial resistance 80:126–133, 80:420 brain drain counter strategies 82:608–615, 82:616–623 censoring of "dangerous," by scientific publishers 81:308–309 civil society perspective 82:757–763 Cochrane Collaboration functions 82:778–783 economic evaluation 82:733–739 ethics see under ethics European support for African 80:843 funding see research funding Gates Foundation targets 81:915–916 gender and poverty issues 82:740–745 gender issues and 10/90 gap 82:162 genetics, training programme 80:176 genome 80:523 Global Forum for Health Research, 2003 conference 82:75–76 health care benefits vs commercial return 82:74–75 health research systems (HRS) framework 81:159, 81:624, 81:815–820 health systems framework for improving 82:720–721 Mexico statement (November 2004) 83:7 implementing "know–do" gap 82:722, 82:723 antenatal care in Thailand 82:746–749 assessing country-level efforts 84:620–628 in clinical practice 82:724–732 policy development in Thailand 82:750–756 see also knowledge translation influencing political manifestos in Nigeria 82:75 international collaboration in Africa 83:482, 83:511–517 genomic epidemiology 84:382–387 global public goods approach 79:869–874 leprosy elimination strategies 83:230–235 "Lessons from the Field" section 83:2 in low- and middle-income countries advance price or purchase commitments to promote 83:301–307 building capacity 82:764–770 Carso Health Institute 85:574–575 creative approach 83:4–5 drug studies 79:894–895 ethical issues 80:114–120 impact of research-tool patents 80:121–125 informed consent 82:771–777 publication in international health literature 82:802–803 role of journals in enhancing 82:163, 82:226–228 setting priorities 85:319–321 tobacco 79:799 malaria, social science approach 80:251–252, 80:683 malaria drugs 84:6–8 maternal mortality 83:86–87, 84:903–909 model for setting priorities 78:1054–1061 musculoskeletal disorders 81:686–688 neglected diseases 80:842–843 stimulating 84:346–348, 84:376–381, 84:414–416 noncommunicable diseases in sub-Saharan Africa 79:947–953 operational ethical approval 84:766 practical approach 85:424 tuberculosis control 80:471–476 pan-African forum 81:71–72 priorities to take forward health equity policy agenda 83:948–953 public–private partnerships see public–private partnerships PubMed Central/E-biomed proposal see PubMed Central Special Programme for Research and Training in Tropical Diseases (TDR) 80:842–843, 85:509–510 STROBE guidelines for observational studies 85:867–872 trustworthiness 83:484 tuberculosis control 85:331–332, 85:410–412 tuberculosis vaccines 80:483–488 US trade embargo ruling on publishing 82:312, 82:394 see also clinical trials/research; drug development; randomized controlled trials research funding in Africa, relevance to burden of disease 83:511–517 health research and development in Brazil 85:124–130 model for setting priorities 78:1054–1061 NIH priority-setting process 77:362–363 tobacco use 79:799 treatments for diseases of poverty 83:301–307 resistin, new hormone 79:273 resource allocation decentralized health systems 78:1024–1035 earmarked donor funding and 82:703–708 equity, and decentralization in Colombia and Chile 81:95–100, 81:914 resources, health AIDS/HIV epidemic 79:1106–1112 needed to attain malaria control goals 85:623–630 profiles, for comparing health systems 78:770–778 stroke outcome and availability 78:1337–1343 tuberculosis control 79:329–336 universal coverage of maternal and newborn health services 85:256–263 see also human resources respiratory diseases chronic, in developing countries 79:971–979 in early childhood, in Brazil 82:516–522 indoor air pollution and 78:1078–1092 respiratory infections, acute see acute respiratory infections respiratory syncytial virus (RSV) epidemiology in Gambia 80:562–568 in four developing countries 82:914–922 RESPIRE trial, pneumonia case-finding in Guatemala 85:535–544 Restructuring health services – changing contexts and comparative perspectives (Sen) 81:546 Return migration: policies and practices in Europe (International Organization for Migration) 83:159 reverse transcription polymerase chain reaction (RT-PCR), viruses in oral fluid 80:76–77 rheumatoid arthritis 81:631 burden